BIAL’s mission is to discover, develop and provide new therapeutic solutions within the area of Health. Today, BIAL is an innovative international pharmaceutical company with products available in more than 55 countries. The company is committed to making a contribution to improve human health and quality of life for people from all over the world. “Caring for your Health” is the Group’s motto, and strategic areas are Innovation, Internationalisation and Quality. Strongly committed to therapeutic innovation, and consistently investing more than 20% of its annual revenue in Research and Development (R&D), BIAL has established an ambitious R&D programme. Key focus areas for the Group are the neurosciences and cardiovascular. BIAL has launched eslicarbazepine acetate, an epilepsy drug, already available in the US and in several European countries. BIAL has also developed a Parkinson’s disease compound, opicapone, also commercialized in Europe. The company expects to introduce new medicines to the market over the next few years, strengthening its international presence.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Chirotech Technology Ltd., a subsidiary of Dr. Reddy's Laboratories Ltd., is a company headquartered in Cambridge, UK, that operates as a dormant company. The firm was founded in 1991.\nThe company says this about itself: Chirotech, a wholly owned subsidiary of Dr Reddy’s is a world-leading bio- and chemocatalysis technology company, providing both products and services to the pharmaceutical industry. Our main focus is developing technical solutions for the production of single enantiomer intermediates and APIs. Our technologies enable cleaner, quicker, and more efficient routes to target chiral molecules. The company was founded more than 20 years ago and has been part of Dr Reddy’s since 2008.

Johnson Matthey is an international speciality chemicals company, founded almost 200 years ago in London. Technology leadership forms the basis of our strategy to deliver superior long term growth

Takasago International Corp. engages in the manufacture and sale of flavors, fragrances, aroma ingredients, and fine chemicals. It operates through the following regional segments: Japan, America, Europe, and Asia. All of the segments handle flavor, fragrances, and aroma ingredients. The Japan segment also deals with fine chemicals and offer real estate leasing and other services. The America Segment also sells fine chemicals. The company was founded by Nanko Kaisho on February 09, 1920 and is headquartered in Tokyo, Japan.

Degussa AG is the world's third largest producer of precious metals. The company operates three divisions; precious metals and banking, which is involved in precious metals trading, production of precious metals and the manufacture of precious metal compounds and products in addition to operating its own bank, 'Degussa Bank', which is a universal bank providing traditional banking services. Chemical products is the second division and is involved in manufacturing fine and special chemicals, rubbers, pigments and chemical catalysts. The third and final division, health and nutrition is involved in manufacturing pharmaceuticals, dental chemicals and fodder additives. The company has subsidiaries in Germany, other European countries, USA, Brazil, Singapore, Japan and South Korea.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Asymchem Laboratories (Tianjin) Co., Ltd. engages in the research and development, and production of intermediates, and active pharmaceutical ingredients. Its business scopes include small molecule contract development and manufacturing organization (CDMO), and emerging service businesses. Its Small Molecule CDMO business provides process development and analysis, clinical drug production, new drug application and approval services, and current good manufacturing practice commercial production services. Its Emerging Service business covers chemical macromolecules, formulations, biosynthesis technology, biological macromolecules, and clinical research services. The company was founded by Hao Hong on October 7, 1998 and is headquartered in Tianjin, China.

ICCAS was founded in 1956. ICCAS is a multi-disciplinary research institute dedicated to the basic research in broad fields of chemical sciences, and to the key developments of the innovative high technologies aiming to the imperative national needs and important strategic targets, as well as to the collaborative high-technology applications and transfers. ICCAS is one of China’s leading chemistry research institutions with high international reputation.

Rhodia Chimie, part of Solvay SA, is a French company located in Aubervilliers that leases intellectual property and patents.

Hubei Zilan Biomedical Technology Co., Ltd., established on 2020-09-08, Business scope includes new drug research and development,organic chemistry,medicinal chemistry,Technology development in biotechnology and related fields,Transfer and provision of advice and services;medicinal compound,Pharmaceutical intermediates and fine chemical products(Does not contain dangerous explosive chemicals and varieties that are restricted by the state)research and development,handicraft Research,pilot test,production and sales;Research and development of plant extracts and related products;food,medicine,Chemicals,primary agricultural products,feed,Medical device testing technical services;Biological product,Water environment analysis and testing service;Teaching Instruments and Equipment,Environmental Monitoring Equipment,first class,Class II medical device,Chemical Products(Does not contain dangerous explosive chemicals and varieties that are restricted by the state),Pharmaceutical Intermediates,Chemical reagents and consumables(Free of hazardous chemicals and medical reagents),glassware,Wholesale, retail and agency of instruments and meters;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)++

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Chiral Quest (Suzhou) Co. Ltd. provides drug discovery services. It focuses on the development and manufacture of chiral catalysts, development of synthetic processes, and a technology applications platform. Its products include a, b, and Cyclicb-amino acids; b-hydroxy acids; chiral amines, alcohols, amino alcohols, and pyrrolidines; succinates; and achiral compounds, a-hydroxy acids, and APIs and intermediates. Chiral Quest has one manufacturing site in Jiangxi province, and three overseas offices in USA, Europe & India respectively. The company was founded by Xumu Zhang in 2000 and is headquartered in Suzhou, China.

Yichang Humanwell Pharmaceuticals Co., Ltd., part of Humanwell Healthcare (Group) Co., Ltd., is a Chinese company located in Yichang that develops and manufactures medicines and pharmaceutical products.

Part of CSPC Pharmaceutical Group Ltd., CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd. is a company headquartered in China. The firm engages in pharmaceutical research and development.

Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany.

Ningbo Pengjun Pharmaceutical Technology Co., Ltd., established on 2015-08-11, Business scope includes pharmaceutical,Technology development in the field of fine chemicals,technology transfer,Technical Advisory Services,And provide the design and transformation of the production process;Chemical raw materials and products(Removal of hazardous chemicals and precursor chemicals),Research on Organic Polymer Materials,to develop,Sales;Self-operated and agent import and export of various goods and technologies,Except for goods and technologies that are restricted by the state or prohibited from import and export.

CSPC NBP Pharmaceutical Co. Ltd. manufactures and sells pharmaceutical products. The firm offers butylphthalide soft capsules and injections, and pharmaceutical raw materials. The company was founded on April 23, 2003 and is headquartered in Shijiazhuang, China.

Dongying Ruigang Investment Promotion Service Co., Ltd., established on 2019-12-26, The scope of business includes attracting investment and attracting talents and management services;Promotion of investment project information,consultation service,Socioeconomic Counseling,Business Management Consulting,Business Incubation and Management Operation(Do not operate in finance,securities,futures,financial management,Fundraising and other related businesses);Conference and Exhibition Services;Entrepreneurial talent introduction consulting and planning services;Corporate Image Planning Service;market survey;Market Management Services;Foreign affairs translation and related services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)